Investigation of the bone density in multiple sclerosis
https://doi.org/10.20538/1682-0363-2008-2-46-51
Abstract
A number of investigations revealed a problem of osteopenic syndrome in patients with multiple sclerosis but there is no common opinion concerning factors which lead to its development. We observed 65 patients with multiple sclerosis with various type of its course and disability status of several degree based upon EDSS scale. Ultrasound osteometry of the calcaneus, computer tomography of QCT of L1—L3 vertebras were performed, serum crosslaps, N-MID osteocalcin were used. Decreased bone density, injured bone microarchitectonics and suppression of bone formation and resorption, which were correlated EDSS were found. Correlations with other factors (growth, weight, gender, and number of steroid therapy sessions ) for these parameters was not revealed. This allowed to conclude that the main reason of decreased bone mass in patients with multiple sclerosis is the dramatic decrease in physical activity.
About the Authors
O. S. Dranichnikova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
V. D. Zavadovskaya
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
V. M. Alifirova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Беневоленская Л.И. Остеопороз — актуальная проблема медицины // Остеопороз и остеопатии. 1998. № 1. С. 4—7.
2. Гусев Е.И., Бойко А.Н. Лечение рассеянного склероза // Лечение нервных болезней. 2004. № 2. С. 3—6.
3. Гусев Е.И., Завалишин И.А., Бойко А.Н. Рассеянный склероз и другие демиелинизирующие заболевания. М.: Миклош, 2004. 540 с.
4. Ершова Н.А., Гармашова Н.В., Бунева В.Н. и др. Уровни антител к ДНК в крови больных рассеянным склерозом в зависимости от клинических характеристик заболевания // Журн. неврологии и психиатрии им. С.С. Корсакова. Спецвып. «Рассеянный склероз». 2003. № 2. С. 25—33.
5. Килина О.Ю. Возможности метода цифрового анализа компьютерных томограмм в диагностике остеопороза: Автореф. дис. … канд. мед. наук. Томск, 2003. 18 с.
6. Насонов Е.Л., Скрипникова И.А. Лечение глюкокортикоидного остеопороза (часть II) // Клинич. медицина. 1997. № 11. С. 14— 19.
7. Шмидт Т.Е. Патогенез, лечение и ведение больных рассеянным склерозом // Невролог. журн. 2003. № 3. С. 46—50.
8. Diagnosis of osteoporosis in men, premenopausal women, and children // J. Clin. Densitom. 2004. Spring. № 7 (1). Р. 17—26.
9. Dovio A., Perazzolo L., Osella G. et al. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis // J. Clin. Endocrinol. Metab. 2004. Oct. № 89 (10). Р. 4923—4928.
10. Ebers G.C. Natural history of multiple sclerosis // J. Neurol. Neurosurg. Psychiatry. 2001. V. 71. P. 16—19.
11. Faulkner M.A., Ryan-Haddad A.M., Lenz T.L., Degner K. Osteoporosis in long-term care residents with multiple sclerosis // Consult. Pharm. 2005. Feb. № 20 (2). Р. 128—136.
12. Formica С.A., Cosman F., Nieves J. et al. Reduced bone mass and fat-free mass in woman with multiple sclerosis: effect of ambulatory status and glucocorticoid use // Calcif. Tissue Int. 1997. V. 61. P. 129—133.
13. Fujita T. Osteoporosis: past, present and future // Osteoporosis Int. 1997. № 7 (Suppl. 3). S6—S9.
14. Kos-Kudla B., Pluskiewicz W. Quantitative ultrasound of the heel and serum and urinary cortisol values in assessment of long-term corticotherapy side effects in female bronchial asthma patients // Ultrasound Med. Biol. 1997. V. 23. № 9. Р. 1325—1330.
15. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) // Neurology. 1983. V. 33. P. 1444—1452.
16. Manolagas S.C. Role Of Cytocinesin Bone Resorption. Bone. 1995. № 16 (1). Abstract 42. P. 9 IS.
17. McDonald et al. Recommended Diagnostic Criteria for MS // Ann. Neurol. 2001.
Review
For citations:
Dranichnikova O.S., Zavadovskaya V.D., Alifirova V.M. Investigation of the bone density in multiple sclerosis. Bulletin of Siberian Medicine. 2008;7(2):46-51. (In Russ.) https://doi.org/10.20538/1682-0363-2008-2-46-51
Views:
475
Email this article 